4D Molecular Therapeutics
2 clinical trials · 2 recruiting · INDUSTRY
Trials by 4D Molecular Therapeutics
RECRUITINGPhase 1 / Phase 2NCT05629559
4D-310 in Adults With Fabry Disease and Cardiac Involvement
This is a prospective multicenter, open-label, dose-escalation trial to assess the safety, tolerability, and pharmacodynamics of 4D-310 following a single IV administration. The...
Sponsor: 4D Molecular TherapeuticsEnrolling: 184 locations
Fabry Disease
RECRUITINGPhase 1 / Phase 2NCT05197270
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Phase 1/2 dose-escalation and randomized, controlled, masked expansion trial in adults with wet AMD undergoing active anti-VEGF treatment. Substudies will evaluate the safety and...
Sponsor: 4D Molecular TherapeuticsEnrolling: 21520 locations
Neovascular (Wet) Age-Related Macular Degeneration